• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

CATEGORIES

  • 7
  • 5
  • 5
  • 4
  • 2
  • 1

PRICE

4
4
4
24

PUBLISHED

1
4
17
24

PRODUCT TYPE

22
2

Search "Lixte Biotechnology Holdings, Inc.-Therapeutic Competitors" returned 24 results.

PRODUCT TITLE

Lixte Biotechnology Holdings, Inc. (LIXT) - Financial and Strategic SWOT Analysis Review

Lixte Biotechnology Holdings, Inc. (LIXT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has...

May 2014
FROM
Competitor Analysis: Enzyme Replacement Therapies Competitor Analysis: Enzyme Replacement Therapies - Product Thumbnail Image

Competitor Analysis: Enzyme Replacement Therapies

The Competitive Intelligence Report Enzyme Replacement & Enhancement Therapies (ERT) as of January 2013 provides a competitor analysis in the development pipeline of novel enzyme replacement therapies...

January 2013
FROM
Lixte Biotechnology Holdings, Inc. (LIXT) - Strategic Analysis Review Lixte Biotechnology Holdings, Inc. (LIXT) - Strategic Analysis Review - Product Thumbnail Image

Lixte Biotechnology Holdings, Inc. (LIXT) - Strategic Analysis Review

Lixte Biotechnology Holdings, Inc. (Lixte) is a research based cancer therapeutics and diagnostics company engaged in development of improved treatments of human cancers. The company is currently developing...

September 2010
FROM

Medulloblastoma - Pipeline Review, H1 2014

Medulloblastoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Medulloblastoma - Pipeline Review, H1 2014’, provides an overview of the Medulloblastoma’s therapeutic pipeline. This...

February 2014
FROM

Neurofibromatoses Type II - Pipeline Review, H1 2014

Neurofibromatoses Type II - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Neurofibromatoses Type II - Pipeline Review, H1 2014’, provides an overview of the Neurofibromatoses Type II’s...

February 2014
FROM

Brain Ischemia - Pipeline Review, H1 2014

Brain Ischemia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Brain Ischemia - Pipeline Review, H1 2014’, provides an overview of the Brain Ischemia’s therapeutic pipeline. This report...

May 2014
FROM

Brain Ischemia - Pipeline Review, H2 2014

Brain Ischemia - Pipeline Review, H2 2014 Summary This, ‘Brain Ischemia - Pipeline Review, H2 2014’, provides an overview of the Brain Ischemia’s therapeutic pipeline. This report provides comprehensive...

November 2014
FROM
Gaucher's Disease - Pipeline Review, H2 2014 Gaucher's Disease - Pipeline Review, H2 2014 - Product Thumbnail Image

Gaucher's Disease - Pipeline Review, H2 2014

Gaucher's Disease - Pipeline Review, H2 2014 Summary This, ‘Gaucher's Disease - Pipeline Review, H2 2014’, provides an overview of the Gaucher's Disease’s therapeutic pipeline. This report provides...

November 2014
FROM

Myocardial Ischemia - Pipeline Review, H1 2015

Myocardial Ischemia - Pipeline Review, H1 2015 Summary This, ‘Myocardial Ischemia - Pipeline Review, H1 2015’, provides an overview of the Myocardial Ischemia’s therapeutic pipeline. This report...

February 2015
FROM

Myocardial Ischemia - Pipeline Review, H2 2014

Myocardial Ischemia - Pipeline Review, H2 2014 Summary This, ‘Myocardial Ischemia - Pipeline Review, H2 2014’, provides an overview of the Myocardial Ischemia’s therapeutic pipeline. This report...

October 2014
FROM

Neurofibromatoses Type II - Pipeline Review, H2 2014

Neurofibromatoses Type II - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Neurofibromatoses Type II - Pipeline Review, H2 2014’, provides an overview of the Neurofibromatoses Type II’s...

July 2014
FROM

Ischemia - Pipeline Review, H2 2014

Ischemia - Pipeline Review, H2 2014 Summary This, ‘Ischemia - Pipeline Review, H2 2014’, provides an overview of the Ischemia’s therapeutic pipeline. This report provides comprehensive information...

December 2014
FROM

Septic Shock - Pipeline Review, H2 2014

Septic Shock - Pipeline Review, H2 2014 Summary This, ‘Septic Shock - Pipeline Review, H2 2014’, provides an overview of the Septic Shock’s therapeutic pipeline. This report provides comprehensive...

December 2014
FROM

Traumatic Brain Injury - Pipeline Review, H2 2014

Traumatic Brain Injury - Pipeline Review, H2 2014 Summary This, ‘Traumatic Brain Injury - Pipeline Review, H2 2014’, provides an overview of the Traumatic Brain Injury’s therapeutic pipeline. This...

October 2014
FROM

Traumatic Brain Injury - Pipeline Review, H1 2014

Traumatic Brain Injury - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Traumatic Brain Injury - Pipeline Review, H1 2014’, provides an overview of the Traumatic Brain Injury’s therapeutic...

April 2014
FROM

Neuroblastoma - Pipeline Review, H1 2014

Neuroblastoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Neuroblastoma - Pipeline Review, H1 2014’, provides an overview of the Neuroblastoma’s therapeutic pipeline. This report...

February 2014
FROM

Gaucher's Disease - Pipeline Review, H1 2015

Gaucher's Disease - Pipeline Review, H1 2015 Summary This, ‘Gaucher's Disease - Pipeline Review, H1 2015’, provides an overview of the Gaucher's Disease’s therapeutic pipeline. This report provides...

January 2015
FROM

Gaucher's Disease - Pipeline Review, H1 2014

Gaucher's Disease - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Gaucher's Disease - Pipeline Review, H1 2014’, provides an overview of the Gaucher's Disease’s therapeutic pipeline. This...

June 2014
FROM

Myocardial Infarction - Pipeline Review, H2 2014

Myocardial Infarction - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Myocardial Infarction - Pipeline Review, H2 2014’, provides an overview of the Myocardial Infarction’s therapeutic...

July 2014
FROM

Myocardial Infarction - Pipeline Review, H1 2014

Myocardial Infarction - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Myocardial Infarction - Pipeline Review, H1 2014’, provides an overview of the Myocardial Infarction’s therapeutic...

February 2014
FROM
Loading Indicator

Our Clients

Goodyear Tire & Rubber Company GlaxoSmithKline PLC Hilton Worldwide Hewlett-Packard Company Accenture PLC. Qualcomm Incorporated UBS AG